Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity

被引：0
|
作者：
机构：
来源：
Int J Radiat Oncol Biol Phys | / 3卷 / 565-570期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Median 5 Year Follow-up of 125Iodine Brachytherapy as Monotherapy in Men Aged ≤55 Years With Favorable Prostate Cancer REPLY
    Crook, Juanita M.
    UROLOGY, 2010, 75 (06) : 1417 - 1417
  • [42] Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer
    Zelefsky, Michael J.
    Yamada, Yoshiya
    Cohen, Gil'ad N.
    SHippy, Alison
    Chan, Heather
    Fridman, David
    Zaider, Marco
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 65 - 70
  • [43] Comment on short-term morbidity and acceptability of 125iodine implantation for localized carcinoma of the prostate by H.!Al-Booz et al (vol 83, pg 55, 1999)
    Kirk, D
    BJU INTERNATIONAL, 1999, 83 (06) : 739 - 739
  • [44] I-125 brachytherapy and localized prostate cancer: Outcome results with 5-year minimum follow-up
    Stone, NN
    Stock, RG
    JOURNAL OF UROLOGY, 2005, 173 (04): : 273 - 274
  • [45] Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate Cancer
    Salami, Simpa S.
    Singhal, Udit
    Spratt, Daniel E.
    Palapattu, Ganesh S.
    Hollenbeck, Brent K.
    Schonhoft, Joseph D.
    Graf, Ryon
    Louw, Jessica
    Jendrisak, Adam
    Dugan, Lyndsey
    Wang, Yipeng
    Tomlins, Scott A.
    Dittamore, Ryan
    Feng, Felix Y.
    Morgan, Todd M.
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 9
  • [46] VMAT SBRT for localized prostate cancer: 5-year update on toxicity and survival
    D'Agostino, G. R.
    Di Brina, L.
    Franzese, C.
    Iftode, C.
    Mancosu, P.
    De Rose, F.
    Clerici, E.
    Reggiori, G.
    Badalamenti, M.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S625 - S626
  • [47] The 5-Year Outcomes of Moderately Hypofractionated Radiation Therapy for Localized Prostate Cancer
    Hashimoto, Y.
    Ishii, Y.
    Kono, S.
    Izumi, S.
    Iizuka, J.
    Karasawa, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E237 - E237
  • [48] Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
    Kristiina Vuolukka
    Päivi Auvinen
    Erno Tiainen
    Jan-Erik Palmgren
    Janne Heikkilä
    Jan Seppälä
    Sirpa Aaltomaa
    Vesa Kataja
    Radiation Oncology, 15
  • [49] Comparison of 5-year outcomes between conformal LDR brachytherapy and high dose IMRT for patients with clinically localized prostate cancer
    Zelefsky, M
    Yamada, J
    Fuks, Z
    Chan, H
    Cohen, G
    Zaider, M
    Leibel, S
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S18 - S18
  • [50] Impact of super-radical prostatectomy on margin status and 5-year progression free survival in clinically localized prostate cancer
    Zimmerman, GE
    Sharma, S
    Kim, HL
    Mohler, JL
    JOURNAL OF UROLOGY, 2006, 175 (04): : 217 - 217
12345